Log in to search using one of your social media accounts:

 

Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials
Publication date: Available online 10 August 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Sanjay Basu, Jeremy B Sussman, Seth A Berkowitz, Rodney A Hayward, John S Yudkin Background In view of substantial mis-estimation of risks of diabetes complications using existing equations, we sought to develop updated Risk Equations for Complications Of type 2 Diabetes (RECODe). Methods To develop and validate these risk equations, we used data from the Action to Control Cardiovascular Risk in Diabetes study (ACCORD, n=9635; 2001–09) and validated the equations for microvascular events using data from th...
Source: The Lancet Diabetes and Endocrinology - August 11, 2017 Category: Endocrinology Source Type: research

New risk equations for complications of type 2 diabetes are welcome, but a broader perspective is needed
Publication date: Available online 10 August 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Coen D A Stehouwer (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - August 11, 2017 Category: Endocrinology Source Type: research

Research digest: more cardiovascular outcome trials in diabetes
Publication date: Available online 9 August 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Naveed Sattar, David Preiss (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - August 10, 2017 Category: Endocrinology Source Type: research

Glucose-lowering drugs: balancing risks and benefits
Publication date: Available online 9 August 2017 Source:The Lancet Diabetes & Endocrinology Author(s): The Lancet Diabetes & Endocrinology (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - August 10, 2017 Category: Endocrinology Source Type: research

How to address non-communicable diseases in urban Africa
Publication date: Available online 7 August 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Jo Hunter-Adams, Blaise Nguendo Yongsi, Kafui Dzasi, Susan Parnell, Jo Ivey Boufford, Edgar Pieterse, Tolu Oni (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - August 8, 2017 Category: Endocrinology Source Type: research

Renal trials in diabetes need a platform: time for a global approach?
Publication date: Available online 7 August 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Dick de Zeeuw, Hiddo J L Heerspink, Meg Jardine, Vlado Perkovic (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - August 8, 2017 Category: Endocrinology Source Type: research

The emotional journey of gestational diabetes
Publication date: Available online 4 August 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Ciara Feighan, Hilary Devine, Usha Daniel, Mensud Hatunic, Mary Frances Higgins (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - August 5, 2017 Category: Endocrinology Source Type: research

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
Publication date: Available online 3 August 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Kåre I Birkeland, Marit E Jørgensen, Bendix Carstensen, Frederik Persson, Hanne L Gulseth, Marcus Thuresson, Peter Fenici, David Nathanson, Thomas Nyström, Jan W Eriksson, Johan Bodegård, Anna Norhammar Background In patients with type 2 diabetes and a high cardiovascular risk profile, the sodium-glucose co-transporter-2 (SGLT2) inhibitors empagliflozin and canagliflozin have been shown to lower cardiovascular morbidity and mortality. Using real-world data from clinical practice, we aimed ...
Source: The Lancet Diabetes and Endocrinology - August 4, 2017 Category: Endocrinology Source Type: research

SGLT2 inhibitors in the real world: too good to be true?
Publication date: Available online 3 August 2017 Source:The Lancet Diabetes & Endocrinology Author(s): David Fitchett (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - August 4, 2017 Category: Endocrinology Source Type: research

Prediabetes: moving away from a glucocentric definition
Publication date: Available online 3 August 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Prashanth R J Vas, K George Alberti, Michael E Edmonds (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - August 4, 2017 Category: Endocrinology Source Type: research

SGTL2 inhibitors and amputations in the US FDA Adverse Event Reporting System
Publication date: Available online 18 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Gian Paolo Fadini, Angelo Avogaro (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 19, 2017 Category: Endocrinology Source Type: research

Correction to Lancet Diabetes Endocrinol 2017; 5: 569 –71
Publication date: August 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 8 (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 19, 2017 Category: Endocrinology Source Type: research

Correction to Lancet Diabetes Endocrinol 2017; 5: 597 –609
Publication date: August 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 8 (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 19, 2017 Category: Endocrinology Source Type: research

Absorbing metabolic illness in India
Publication date: August 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 8 Author(s): Emily Yates-Doerr (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 19, 2017 Category: Endocrinology Source Type: research

Oldest case of gigantism? Assessment of the alleged remains of Sa-Nakht, king of ancient Egypt
Publication date: August 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 8 Author(s): Francesco M Galassi, Maciej Henneberg, Wouter de Herder, Frank Rühli, Michael E Habicht (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 19, 2017 Category: Endocrinology Source Type: research

Microvascular outcomes in type 2 diabetes – Authors' reply
Publication date: August 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 8 Author(s): Sophia Zoungas, Hertzel C Gerstein, Rury R Holman, Peter Reaven, Mark Woodward, Hisatomi Arima, Ruth L Coleman, John Chalmers (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 19, 2017 Category: Endocrinology Source Type: research

Microvascular outcomes in type 2 diabetes
Publication date: August 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 8 Author(s): Coen D A Stehouwer, Thomas T van Sloten (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 19, 2017 Category: Endocrinology Source Type: research

Hyperglycaemia in pregnancy: time to ask the hard questions?
Publication date: August 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 8 Author(s): Uma Ram, Suresh Seshadri, Ponnusamy Saravanan (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 19, 2017 Category: Endocrinology Source Type: research

Forging paths to improve diabetes care in low-income settings
Publication date: August 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 8 Author(s): The Lancet Diabetes & Endocrinology (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 19, 2017 Category: Endocrinology Source Type: research

Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data
Publication date: Available online 14 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Kunihiro Matsushita, Shoshana H Ballew, Josef Coresh, Hisatomi Arima, Johan Ärnlöv, Massimo Cirillo, Natalie Ebert, Jade S Hiramoto, Heejin Kimm, Michael G Shlipak, Frank L J Visseren, Ron T Gansevoort, Csaba P Kovesdy, Varda Shalev, Mark Woodward, Florian Kronenberg Background Some evidence suggests that chronic kidney disease is a risk factor for lower-extremity peripheral artery disease. We aimed to quantify the independent and joint associations of two measures of chronic kidney disease (estimated gl...
Source: The Lancet Diabetes and Endocrinology - July 15, 2017 Category: Endocrinology Source Type: research

Common measures of chronic kidney disease improve vascular risk prediction
Publication date: Available online 14 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Austin G Stack (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 15, 2017 Category: Endocrinology Source Type: research

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial
This study is registered with ClinicalTrials.gov, number NCT02282397. Findings Between April 14, 2015, and May 5, 2016, 37 participants were randomly assigned to the CGM plus CSII group and 38 participants were randomly assigned to the CGM plus MDI group. The study was completed by 36 (97%) of 37 participants in the CGM plus CSII group and 35 (92%) of 38 participants in the CGM plus MDI group. Mean CGM use was 6·7 days per week (SD 0·8) in the CGM plus CSII group and 6·9 days per week (0·3) in the CGM plus MDI group (p=0·86). No participants in the CGM plus CSII group who completed the tr...
Source: The Lancet Diabetes and Endocrinology - July 13, 2017 Category: Endocrinology Source Type: research

Looking again at the Look AHEAD study
Publication date: Available online 12 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Edward W Gregg, Rena Wing (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 13, 2017 Category: Endocrinology Source Type: research

Sensor mightier than pump —the jury is still out
Publication date: Available online 12 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Roman Hovorka (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 13, 2017 Category: Endocrinology Source Type: research

Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial
Publication date: Available online 12 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Aaron Baum, Joseph Scarpa, Emilie Bruzelius, Ronald Tamler, Sanjay Basu, James Faghmous Background The Action for Health in Diabetes (Look AHEAD) trial investigated whether long-term cardiovascular disease morbidity and mortality could be reduced through a weight loss intervention among people with type 2 diabetes. Despite finding no significant reduction in cardiovascular events on average, it is possible that some subpopulations might have derived benefit. In this post-hoc analysis, we test the hypothesis that t...
Source: The Lancet Diabetes and Endocrinology - July 13, 2017 Category: Endocrinology Source Type: research

Osteoporosis treatment: recent developments and ongoing challenges
Publication date: Available online 7 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Sundeep Khosla, Lorenz C Hofbauer Osteoporosis is an enormous and growing public health problem. Once considered an inevitable consequence of ageing, it is now eminently preventable and treatable. Ironically, despite tremendous therapeutic advances, there is an increasing treatment gap for patients at high fracture risk. In this Series paper, we trace the evolution of drug therapy for osteoporosis, which began in the 1940s with the demonstration by Fuller Albright that treatment with oestrogen could reverse the neg...
Source: The Lancet Diabetes and Endocrinology - July 8, 2017 Category: Endocrinology Source Type: research

Use of bone turnover markers in postmenopausal osteoporosis
Publication date: Available online 7 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Richard Eastell, Pawel Szulc Bone turnover comprises two processes: the removal of old bone (resorption) and the laying down of new bone (formation). N-terminal propeptide of type I procollagen (PINP) and C-telopeptide of type I collagen (CTX-I) are markers of bone formation and resorption, respectively, that are recommended for clinical use. Bone turnover markers can be measured on several occasions in one individual with good precision. However, these markers are subject to several sources of variability, includi...
Source: The Lancet Diabetes and Endocrinology - July 8, 2017 Category: Endocrinology Source Type: research

Diabetes in sub-Saharan Africa: let us not forget type 1
Publication date: Available online 5 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Silver K Bahendeka (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 6, 2017 Category: Endocrinology Source Type: research

Diabetes in sub-Saharan Africa: from clinical care to health policy
Publication date: Available online 5 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Rifat Atun, Justine I Davies, Edwin A M Gale, Till Bärnighausen, David Beran, Andre Pascal Kengne, Naomi S Levitt, Florence W Mangugu, Moffat J Nyirenda, Graham D Ogle, Kaushik Ramaiya, Nelson K Sew.ambo, Eugene Sobngwi, Solomon Tesfaye, John S Yudkin, Sanjay Basu, Christian Bommer, Esther Heesemann, Jennifer Manne-Goehler, Iryna Postolovska, Vera Sagalova, Sebastian Vollmer, Zulfiqarali G Abbas, Benjamin Ammon, Mulugeta Terekegn Angamo, Akhila Annamreddi, Ananya Awasthi, Stéphane Besançon, Sudha...
Source: The Lancet Diabetes and Endocrinology - July 6, 2017 Category: Endocrinology Source Type: research

The crisis of diabetes in sub-Saharan Africa
Publication date: Available online 5 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Shabbar Jaffar, Geoffrey Gill (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - July 6, 2017 Category: Endocrinology Source Type: research

SGLT2 inhibition: a new era in renoprotective medicine?
Publication date: Available online 27 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Marcel H A Muskiet, Hiddo J L Heerspink, Daniël H van Raalte (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 28, 2017 Category: Endocrinology Source Type: research

Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
This study is completed and registered with ClinicalTrials.gov, number NCT01131676. Findings Between Sept 1, 2010, and April 22, 2013, we randomly assigned 7028 patients to treatment groups and 7020 patients received treatment. At baseline, we had UACR data for 6953 patients: 4171 (59% of treated patients; 1382 assigned to placebo and 2789 assigned to empagliflozin) had normoalbuminuria, 2013 (29%; 675 assigned to placebo and 1338 assigned to empagliflozin) had microalbuminuria, and 769 (11%; 260 assigned to placebo and 509 assigned to empagliflozin) had macroalbuminuria. Median treatment duration was 2·6 years (IQR...
Source: The Lancet Diabetes and Endocrinology - June 28, 2017 Category: Endocrinology Source Type: research

Sacubitril/valsartan in PARADIGM-HF – Authors' reply
Publication date: July 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 7 Author(s): Jelena P Seferovic, Brian Claggett, Scott D Solomon (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 21, 2017 Category: Endocrinology Source Type: research

Sacubitril/valsartan in PARADIGM-HF
Publication date: July 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 7 Author(s): Maya Guglin (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 21, 2017 Category: Endocrinology Source Type: research

The role of biosimilar manufacturers in improving access to insulin globally
Publication date: Available online 16 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Christophe Perrin, Margaret Ewen, David Beran (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 17, 2017 Category: Endocrinology Source Type: research

Metformin in type 1 diabetes
Publication date: Available online 11 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Eberhard Standl (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 13, 2017 Category: Endocrinology Source Type: research

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
Publication date: Available online 11 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): John R Petrie, Nishi Chaturvedi, Ian Ford, Martijn C G J Brouwers, Nicola Greenlaw, Therese Tillin, Irene Hramiak, Alun D Hughes, Alicia J Jenkins, Barbara E K Klein, Ronald Klein, Teik C Ooi, Peter Rossing, Coen D A Stehouwer, Naveed Sattar, Helen M Colhoun Background Metformin might reduce insulin requirement and improve glycaemia in patients with type 1 diabetes, but whether it has cardiovascular benefits is unknown. We aimed to investigate whether metformin treatment (added to titrated insulin therapy) reduced...
Source: The Lancet Diabetes and Endocrinology - June 13, 2017 Category: Endocrinology Source Type: research

Person-centred type 2 diabetes care: time for a paradigm shift
Publication date: Available online 9 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Guy E H M Rutten, Aus Alzaid (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 10, 2017 Category: Endocrinology Source Type: research

Correction to Lancet Diabetes Endocrinol 2017; published online June 7. http://dx.doi.org/10.1016/S2213-8587(17)30174-2
Publication date: Available online 8 June 2017 Source:The Lancet Diabetes & Endocrinology (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 9, 2017 Category: Endocrinology Source Type: research

Should we officially recognise obesity as a disease?
Publication date: Available online 7 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): The Lancet Diabetes & Endocrinology (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 8, 2017 Category: Endocrinology Source Type: research

Research digest: topical trials in thyroid disease
Publication date: Available online 7 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): David Preiss, Steve Cleland, Naveed Sattar (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 8, 2017 Category: Endocrinology Source Type: research

Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR –INDIAB population-based cross-sectional study
Publication date: Available online 7 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Ranjit Mohan Anjana, Mohan Deepa, Rajendra Pradeepa, Jagadish Mahanta, Kanwar Narain, Hiranya Kumar Das, Prabha Adhikari, Paturi Vishnupriya Rao, Banshi Saboo, Ajay Kumar, Anil Bhansali, Mary John, Rosang Luaia, Taranga Reang, Somorjit Ningombam, Lobsang Jampa, Richard O Budnah, Nirmal Elangovan, Radhakrishnan Subashini, Ulagamathesan Venkatesan, Ranjit Unnikrishnan, Ashok Kumar Das, Sri Venkata Madhu, Mohammed K Ali, Arvind Pandey, Rupinder Singh Dhaliwal, Tanvir Kaur, Soumya Swaminathan, Viswanathan Mohan Backgro...
Source: The Lancet Diabetes and Endocrinology - June 8, 2017 Category: Endocrinology Source Type: research

The need for improved diabetes care in India
Publication date: Available online 7 June 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Vijay Viswanathan (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - June 8, 2017 Category: Endocrinology Source Type: research

Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
Publication date: Available online 30 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Tracy A Williams, Jacques W M Lenders, Paolo Mulatero, Jacopo Burrello, Marietta Rottenkolber, Christian Adolf, Fumitoshi Satoh, Laurence Amar, Marcus Quinkler, Jaap Deinum, Felix Beuschlein, Kanako K Kitamoto, Uyen Pham, Ryo Morimoto, Hironobu Umakoshi, Aleksander Prejbisz, Tomaz Kocjan, Mitsuhide Naruse, Michael Stowasser, Tetsuo Nishikawa, William F Young, Celso E Gomez-Sanchez, John W Funder, Martin Reincke Background Although unilateral primary aldosteronism is the most common surgically correctable cause of h...
Source: The Lancet Diabetes and Endocrinology - May 31, 2017 Category: Endocrinology Source Type: research

Rating the blood pressure outcome after adrenalectomy for unilateral primary aldosteronism
Publication date: Available online 30 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Olivier Steichen (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 31, 2017 Category: Endocrinology Source Type: research

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
Publication date: Available online 26 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Stephen Zewinger, Marcus E Kleber, Vinicius Tragante, Raymond O McCubrey, Amand F Schmidt, Kenan Direk, Ulrich Laufs, Christian Werner, Wolfgang Koenig, Dietrich Rothenbacher, Ute Mons, Lutz P Breitling, Herrmann Brenner, Richard T Jennings, Ioannis Petrakis, Sarah Triem, Mira Klug, Alexandra Filips, Stefan Blankenberg, Christoph Waldeyer, Christoph Sinning, Renate B Schnabel, Karl J Lackner, Efthymia Vlachopoulou, Ottar Nygård, Gard Frodahl Tveitevåg Svingen, Eva Ringdal Pedersen, Grethe S Tell, Juha S...
Source: The Lancet Diabetes and Endocrinology - May 27, 2017 Category: Endocrinology Source Type: research

Lipoprotein(a) and cardiovascular mortality: mystery still unsolved
Publication date: Available online 26 May 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Raul D Santos (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 27, 2017 Category: Endocrinology Source Type: research

Access to insulin: patients will pave the way
Publication date: June 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 6 Author(s): Elizabeth R Rowley, James A Elliott, Fiona Conner, Philip Reed, John A Rowley (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 25, 2017 Category: Endocrinology Source Type: research

Gestational vitamin D and childhood bone health – Authors' reply
Publication date: June 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 6 Author(s): Audry H García, Oscar H Franco, Trudy Voortman (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 25, 2017 Category: Endocrinology Source Type: research

Gestational vitamin D and childhood bone health
Publication date: June 2017 Source:The Lancet Diabetes & Endocrinology, Volume 5, Issue 6 Author(s): Nicholas C Harvey, Rebecca Moon, Hazel M Inskip, Keith M Godfrey, Cyrus Cooper (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - May 25, 2017 Category: Endocrinology Source Type: research